<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The prevalence of <z:mp ids='MP_0002055'>diabetes</z:mp> is high among patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the prevalence of abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and clinical characteristics among patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> in the Chinese population is uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the prevalence of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> in Chinese patients after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> in a nationwide cohort study and investigated abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> across China (ACROSS-China) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The ACROSS-China study consecutively recruited patients hospitalized for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> in 2008 to 2009 and investigated the prevalence of <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> among the patients on day 14 after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test was performed in the diagnosis of abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The prevalence of abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation was 68.7% among <z:hpo ids='HP_0000001'>all</z:hpo> the patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> was identified in 42.3% of <z:hpo ids='HP_0000001'>all</z:hpo> the patients (45.8% for patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, 31.2% for patients with <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo>, and 26.4% for patients with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">Prediabetes</z:e> (impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>) was identified in 26.4% of <z:hpo ids='HP_0000001'>all</z:hpo> the patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The prevalence of <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> was the highest in the patients with atherothrombotic infarction (73.4%) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The prevalence of abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation was high in Chinese patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo>, especially in patients with atherothrombotic infarction </plain></SENT>
<SENT sid="10" pm="."><plain>Oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test identified a large percentage of patients with newly diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
</text></document>